Reduced bleeding with genotype-guided antiplatelet therapy

Nature Reviews Cardiology, Published online: 16 September 2019; doi:10.1038/s41569-019-0276-0Genotype-guided selection of oral P2Y12 inhibitor therapy (clopidogrel versus prasugrel or ticagrelor) can reduce the incidence of bleeding in patients who have undergone primary percutaneous coronary intervention.

Source: Nature Reviews Cardiology - September 15, 2019 Category: Cardiology Authors: Gregory B. Lim Source Type: research